These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8403559)

  • 21. Therapeutic efficacy of a soluble receptor activator of nuclear factor kappaB-IgG Fc fusion protein in suppressing bone resorption and hypercalcemia in a model of humoral hypercalcemia of malignancy.
    Oyajobi BO; Anderson DM; Traianedes K; Williams PJ; Yoneda T; Mundy GR
    Cancer Res; 2001 Mar; 61(6):2572-8. PubMed ID: 11289133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppression of tumor angiogenesis and growth by gene transfer of a soluble form of vascular endothelial growth factor receptor into a remote organ.
    Takayama K; Ueno H; Nakanishi Y; Sakamoto T; Inoue K; Shimizu K; Oohashi H; Hara N
    Cancer Res; 2000 Apr; 60(8):2169-77. PubMed ID: 10786681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor necrosis factor receptor: Fc fusion protein in septic shock.
    Whiteley MS
    N Engl J Med; 1996 Nov; 335(21):1607-8; author reply 1608-9. PubMed ID: 8927111
    [No Abstract]   [Full Text] [Related]  

  • 24. Tumor necrosis factor receptor: Fc fusion protein in septic shock.
    Glauser MP; Cohen J
    N Engl J Med; 1996 Nov; 335(21):1608; author reply 1608-9. PubMed ID: 8927112
    [No Abstract]   [Full Text] [Related]  

  • 25. Acute inhibition of myostatin-family proteins preserves skeletal muscle in mouse models of cancer cachexia.
    Benny Klimek ME; Aydogdu T; Link MJ; Pons M; Koniaris LG; Zimmers TA
    Biochem Biophys Res Commun; 2010 Jan; 391(3):1548-54. PubMed ID: 20036643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment with the interleukin-I receptor antagonist and soluble tumor necrosis factor receptor Fc fusion protein does not prevent endotoxin-induced preterm parturition in mice.
    Fidel PL; Romero R; Cutright J; Wolf N; Gomez R; Araneda H; Ramirez M; Yoon BH
    J Soc Gynecol Investig; 1997; 4(1):22-6. PubMed ID: 9051630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of biological response modifiers on growth and cell proliferation of human tumor xenografts in nude mice.
    Maurer-Schultze B; Bassukas ID; Hofmockel G
    Cell Mol Biol (Noisy-le-grand); 1995 Feb; 41(1):65-78. PubMed ID: 7773138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists.
    Mohler KM; Torrance DS; Smith CA; Goodwin RG; Stremler KE; Fung VP; Madani H; Widmer MB
    J Immunol; 1993 Aug; 151(3):1548-61. PubMed ID: 8393046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cytokines in experimental cancer cachexia].
    Niu Q; Li T; Liu A
    Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):382-4. PubMed ID: 11810767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TNF receptor II fusion protein with tandemly repeated Fc domains.
    Nagashima H; Kaneko K; Yamanoi A; Motoi S; Konakahara S; Kohroki J; Masuho Y
    J Biochem; 2011 Mar; 149(3):337-46. PubMed ID: 21278157
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor necrosis factor receptor: Fc fusion protein does not improve septic shock and may increase mortality in human.
    Atallah AN
    Sao Paulo Med J; 1996; 114(3):1151. PubMed ID: 9181744
    [No Abstract]   [Full Text] [Related]  

  • 32. Metabolic effects of cachectin/tumor necrosis factor are modified by site of production. Cachectin/tumor necrosis factor-secreting tumor in skeletal muscle induces chronic cachexia, while implantation in brain induces predominantly acute anorexia.
    Tracey KJ; Morgello S; Koplin B; Fahey TJ; Fox J; Aledo A; Manogue KR; Cerami A
    J Clin Invest; 1990 Dec; 86(6):2014-24. PubMed ID: 2254457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention of adenocarcinoma colon 26-induced cachexia by interleukin 10 gene transfer.
    Fujiki F; Mukaida N; Hirose K; Ishida H; Harada A; Ohno S; Bluethmann H; Kawakami M; Akiyama M; Sone S; Matsushima K
    Cancer Res; 1997 Jan; 57(1):94-9. PubMed ID: 8988047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of therapy with soluble tumour necrosis factor receptor fusion protein on pulmonary cytokine expression and lung injury following haemorrhage and resuscitation.
    Abraham E; Coulson WF; Schwartz MD; Allbee J
    Clin Exp Immunol; 1994 Oct; 98(1):29-34. PubMed ID: 7923880
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence that tumor necrosis factor plays a pathogenetic role in the paraneoplastic syndromes of cachexia, hypercalcemia, and leukocytosis in a human tumor in nude mice.
    Yoneda T; Alsina MA; Chavez JB; Bonewald L; Nishimura R; Mundy GR
    J Clin Invest; 1991 Mar; 87(3):977-85. PubMed ID: 1999505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of tumor necrosis factor activity fails to restore 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced suppression of the antibody response to sheep red blood cells.
    Moos AB; Kerkvliet NI
    Toxicol Lett; 1995 Nov; 81(2-3):175-81. PubMed ID: 8553372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nociceptive characteristics of tumor necrosis factor-alpha in naive and tumor-bearing mice.
    Wacnik PW; Eikmeier LJ; Simone DA; Wilcox GL; Beitz AJ
    Neuroscience; 2005; 132(2):479-91. PubMed ID: 15802198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beneficial effects of the transgenic expression of human sTNF-αR-Fc and HO-1 on pig-to-mouse islet xenograft survival.
    Yan JJ; Yeom HJ; Jeong JC; Lee JG; Lee EW; Cho B; Lee HS; Kim SJ; Hwang JI; Kim SJ; Lee BC; Ahn C; Yang J
    Transpl Immunol; 2016 Feb; 34():25-32. PubMed ID: 26777482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of cancer cachexia by pyrrolidine dithiocarbamate (PDTC) in colon 26 tumor-bearing mice.
    Nai YJ; Jiang ZW; Wang ZM; Li N; Li JS
    JPEN J Parenter Enteral Nutr; 2007; 31(1):18-25. PubMed ID: 17202436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Murine interleukin-12 prevents the development of cancer cachexia in a murine model.
    Mori K; Fujimoto-Ouchi K; Ishikawa T; Sekiguchi F; Ishitsuka H; Tanaka Y
    Int J Cancer; 1996 Sep; 67(6):849-55. PubMed ID: 8824558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.